Loading…

The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro

Bone marrow aspirate concentrate (BMC) is commonly used as a therapeutic agent to resolve orthopedic injuries, using its unique cellularity to reduce inflammation and prime the region for repair. The aspiration of the bone marrow is performed using either sodium citrate (SC) or heparin sodium (HS) a...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells international 2022-07, Vol.2022, p.1-12
Main Authors: Dregalla, Ryan C., Herrera, Jessica Ann, Koldewyn, Lucanus Steven, Donner, Edward Jeffery
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13
cites cdi_FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13
container_end_page 12
container_issue
container_start_page 1
container_title Stem cells international
container_volume 2022
creator Dregalla, Ryan C.
Herrera, Jessica Ann
Koldewyn, Lucanus Steven
Donner, Edward Jeffery
description Bone marrow aspirate concentrate (BMC) is commonly used as a therapeutic agent to resolve orthopedic injuries, using its unique cellularity to reduce inflammation and prime the region for repair. The aspiration of the bone marrow is performed using either sodium citrate (SC) or heparin sodium (HS) as an anticoagulant and processed via centrifugation to concentrate the cellular constituents. To date, the consideration of the impact of the two commonly used anticoagulants on the mesenchymal stem/stromal cell (MSC) population has been overlooked. The current study assesses the differences in the BMCs produced using 15% SC and HS at 1,000 U/mL or 100 U/mL final v./v. as an anticoagulant using in vitro metrics including total nucleated cell counts (TNC) and viability, the ability for mesenchymal stromal/stem cells (MSCs) to establish colony-forming units with fibroblast morphology (CFU-f), and cytokine expression profile of the MSC cultures. Our findings demonstrate that HS-derived BMC cultures result in higher CFU-f formation and CFU-f frequency at both concentrations assessed compared to SC-derived BMC cultures. In addition, there were significant differences in 27% (7 of 26) of the cytokines quantified in HS-derived BMC cultures compared to SC-derived BMC cultures with implications for MSC plasticity and self-renewal.
doi_str_mv 10.1155/2022/8259888
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6b25d11a690242ff8b82a430e592b8e6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712138548</galeid><doaj_id>oai_doaj_org_article_6b25d11a690242ff8b82a430e592b8e6</doaj_id><sourcerecordid>A712138548</sourcerecordid><originalsourceid>FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13</originalsourceid><addsrcrecordid>eNp9kt1q2zAUgM3YWEvXuz2AYTAGW1pJjv5uBmnYT6BlF-vG7oRiHccKtpRKckseYu88OQndMsZsjMXRdz5xjk5RvMToAmNKLwki5FIQKoUQT4pTzASfSMbF08c1-3FSnMe4RvmpJJoi8rw4qajEiFb0tPh520I5b72tofRNOXPJ1l6vhk67VC5c0w3gaohl2mE66DpBsDFTceSvvIPyRofgH8pZ3NigU-Z8TnFpt9bOlDcQs6Td9rorvyboyzl0XXllfZbZe5u2-aDyu03BvyieNbqLcH74nxXfPn64nX-eXH_5tJjPric1xTJNKoIwQYYLDAYosIYBrjnnLMcAE4moJsQwUxuDhMSGU17phkoupOaNwdVZsdh7jddrtQm212GrvLZqF_BhpXTINXag2JJQg7FmEpEpaRqxFERPKwRUkqUAll3v967NsOzB7CvvjqTHO862auXvlawqLqckC94cBMHfDRCT6m2sc4u0Az9ERZjkSObrFBl99Re69kNwuVUjxXgl8vebWulcgHWNz-fWo1TNOCa4EnQ6ui7-QeXXQJ9nwEFjc_wo4fUfCS3oLrXRd0Oy3sVj8N0erIOPMUDz2AyM1Di2ahxbdRjbjL_d4611Rj_Y_9O_AMIV6Qk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696738673</pqid></control><display><type>article</type><title>The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro</title><source>PubMed (Medline)</source><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><creator>Dregalla, Ryan C. ; Herrera, Jessica Ann ; Koldewyn, Lucanus Steven ; Donner, Edward Jeffery</creator><contributor>Mezey, Eva</contributor><creatorcontrib>Dregalla, Ryan C. ; Herrera, Jessica Ann ; Koldewyn, Lucanus Steven ; Donner, Edward Jeffery ; Mezey, Eva</creatorcontrib><description>Bone marrow aspirate concentrate (BMC) is commonly used as a therapeutic agent to resolve orthopedic injuries, using its unique cellularity to reduce inflammation and prime the region for repair. The aspiration of the bone marrow is performed using either sodium citrate (SC) or heparin sodium (HS) as an anticoagulant and processed via centrifugation to concentrate the cellular constituents. To date, the consideration of the impact of the two commonly used anticoagulants on the mesenchymal stem/stromal cell (MSC) population has been overlooked. The current study assesses the differences in the BMCs produced using 15% SC and HS at 1,000 U/mL or 100 U/mL final v./v. as an anticoagulant using in vitro metrics including total nucleated cell counts (TNC) and viability, the ability for mesenchymal stromal/stem cells (MSCs) to establish colony-forming units with fibroblast morphology (CFU-f), and cytokine expression profile of the MSC cultures. Our findings demonstrate that HS-derived BMC cultures result in higher CFU-f formation and CFU-f frequency at both concentrations assessed compared to SC-derived BMC cultures. In addition, there were significant differences in 27% (7 of 26) of the cytokines quantified in HS-derived BMC cultures compared to SC-derived BMC cultures with implications for MSC plasticity and self-renewal.</description><identifier>ISSN: 1687-966X</identifier><identifier>ISSN: 1687-9678</identifier><identifier>EISSN: 1687-9678</identifier><identifier>DOI: 10.1155/2022/8259888</identifier><identifier>PMID: 35910535</identifier><language>eng</language><publisher>New York: Hindawi</publisher><subject>Anticoagulants ; Anticoagulants (Medicine) ; Biological activity ; Bone marrow ; Cell culture ; Cell self-renewal ; Centrifugation ; Chemical compounds ; Cytokines ; Cytology ; Fibroblasts ; Health aspects ; Heparin ; Influence ; Injury prevention ; Mesenchymal stem cells ; Morphology ; Orthopedics ; Pharmacology ; Sodium ; Sodium citrate ; Stem cells</subject><ispartof>Stem cells international, 2022-07, Vol.2022, p.1-12</ispartof><rights>Copyright © 2022 Ryan C. Dregalla et al.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2022 Ryan C. Dregalla et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Ryan C. Dregalla et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13</citedby><cites>FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13</cites><orcidid>0000-0001-7091-296X ; 0000-0002-7516-4849 ; 0000-0002-9872-8758 ; 0000-0003-3139-4164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2696738673/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2696738673?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids></links><search><contributor>Mezey, Eva</contributor><creatorcontrib>Dregalla, Ryan C.</creatorcontrib><creatorcontrib>Herrera, Jessica Ann</creatorcontrib><creatorcontrib>Koldewyn, Lucanus Steven</creatorcontrib><creatorcontrib>Donner, Edward Jeffery</creatorcontrib><title>The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro</title><title>Stem cells international</title><description>Bone marrow aspirate concentrate (BMC) is commonly used as a therapeutic agent to resolve orthopedic injuries, using its unique cellularity to reduce inflammation and prime the region for repair. The aspiration of the bone marrow is performed using either sodium citrate (SC) or heparin sodium (HS) as an anticoagulant and processed via centrifugation to concentrate the cellular constituents. To date, the consideration of the impact of the two commonly used anticoagulants on the mesenchymal stem/stromal cell (MSC) population has been overlooked. The current study assesses the differences in the BMCs produced using 15% SC and HS at 1,000 U/mL or 100 U/mL final v./v. as an anticoagulant using in vitro metrics including total nucleated cell counts (TNC) and viability, the ability for mesenchymal stromal/stem cells (MSCs) to establish colony-forming units with fibroblast morphology (CFU-f), and cytokine expression profile of the MSC cultures. Our findings demonstrate that HS-derived BMC cultures result in higher CFU-f formation and CFU-f frequency at both concentrations assessed compared to SC-derived BMC cultures. In addition, there were significant differences in 27% (7 of 26) of the cytokines quantified in HS-derived BMC cultures compared to SC-derived BMC cultures with implications for MSC plasticity and self-renewal.</description><subject>Anticoagulants</subject><subject>Anticoagulants (Medicine)</subject><subject>Biological activity</subject><subject>Bone marrow</subject><subject>Cell culture</subject><subject>Cell self-renewal</subject><subject>Centrifugation</subject><subject>Chemical compounds</subject><subject>Cytokines</subject><subject>Cytology</subject><subject>Fibroblasts</subject><subject>Health aspects</subject><subject>Heparin</subject><subject>Influence</subject><subject>Injury prevention</subject><subject>Mesenchymal stem cells</subject><subject>Morphology</subject><subject>Orthopedics</subject><subject>Pharmacology</subject><subject>Sodium</subject><subject>Sodium citrate</subject><subject>Stem cells</subject><issn>1687-966X</issn><issn>1687-9678</issn><issn>1687-9678</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kt1q2zAUgM3YWEvXuz2AYTAGW1pJjv5uBmnYT6BlF-vG7oRiHccKtpRKckseYu88OQndMsZsjMXRdz5xjk5RvMToAmNKLwki5FIQKoUQT4pTzASfSMbF08c1-3FSnMe4RvmpJJoi8rw4qajEiFb0tPh520I5b72tofRNOXPJ1l6vhk67VC5c0w3gaohl2mE66DpBsDFTceSvvIPyRofgH8pZ3NigU-Z8TnFpt9bOlDcQs6Td9rorvyboyzl0XXllfZbZe5u2-aDyu03BvyieNbqLcH74nxXfPn64nX-eXH_5tJjPric1xTJNKoIwQYYLDAYosIYBrjnnLMcAE4moJsQwUxuDhMSGU17phkoupOaNwdVZsdh7jddrtQm212GrvLZqF_BhpXTINXag2JJQg7FmEpEpaRqxFERPKwRUkqUAll3v967NsOzB7CvvjqTHO862auXvlawqLqckC94cBMHfDRCT6m2sc4u0Az9ERZjkSObrFBl99Re69kNwuVUjxXgl8vebWulcgHWNz-fWo1TNOCa4EnQ6ui7-QeXXQJ9nwEFjc_wo4fUfCS3oLrXRd0Oy3sVj8N0erIOPMUDz2AyM1Di2ahxbdRjbjL_d4611Rj_Y_9O_AMIV6Qk</recordid><startdate>20220722</startdate><enddate>20220722</enddate><creator>Dregalla, Ryan C.</creator><creator>Herrera, Jessica Ann</creator><creator>Koldewyn, Lucanus Steven</creator><creator>Donner, Edward Jeffery</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7091-296X</orcidid><orcidid>https://orcid.org/0000-0002-7516-4849</orcidid><orcidid>https://orcid.org/0000-0002-9872-8758</orcidid><orcidid>https://orcid.org/0000-0003-3139-4164</orcidid></search><sort><creationdate>20220722</creationdate><title>The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro</title><author>Dregalla, Ryan C. ; Herrera, Jessica Ann ; Koldewyn, Lucanus Steven ; Donner, Edward Jeffery</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants (Medicine)</topic><topic>Biological activity</topic><topic>Bone marrow</topic><topic>Cell culture</topic><topic>Cell self-renewal</topic><topic>Centrifugation</topic><topic>Chemical compounds</topic><topic>Cytokines</topic><topic>Cytology</topic><topic>Fibroblasts</topic><topic>Health aspects</topic><topic>Heparin</topic><topic>Influence</topic><topic>Injury prevention</topic><topic>Mesenchymal stem cells</topic><topic>Morphology</topic><topic>Orthopedics</topic><topic>Pharmacology</topic><topic>Sodium</topic><topic>Sodium citrate</topic><topic>Stem cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dregalla, Ryan C.</creatorcontrib><creatorcontrib>Herrera, Jessica Ann</creatorcontrib><creatorcontrib>Koldewyn, Lucanus Steven</creatorcontrib><creatorcontrib>Donner, Edward Jeffery</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Stem cells international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dregalla, Ryan C.</au><au>Herrera, Jessica Ann</au><au>Koldewyn, Lucanus Steven</au><au>Donner, Edward Jeffery</au><au>Mezey, Eva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro</atitle><jtitle>Stem cells international</jtitle><date>2022-07-22</date><risdate>2022</risdate><volume>2022</volume><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1687-966X</issn><issn>1687-9678</issn><eissn>1687-9678</eissn><abstract>Bone marrow aspirate concentrate (BMC) is commonly used as a therapeutic agent to resolve orthopedic injuries, using its unique cellularity to reduce inflammation and prime the region for repair. The aspiration of the bone marrow is performed using either sodium citrate (SC) or heparin sodium (HS) as an anticoagulant and processed via centrifugation to concentrate the cellular constituents. To date, the consideration of the impact of the two commonly used anticoagulants on the mesenchymal stem/stromal cell (MSC) population has been overlooked. The current study assesses the differences in the BMCs produced using 15% SC and HS at 1,000 U/mL or 100 U/mL final v./v. as an anticoagulant using in vitro metrics including total nucleated cell counts (TNC) and viability, the ability for mesenchymal stromal/stem cells (MSCs) to establish colony-forming units with fibroblast morphology (CFU-f), and cytokine expression profile of the MSC cultures. Our findings demonstrate that HS-derived BMC cultures result in higher CFU-f formation and CFU-f frequency at both concentrations assessed compared to SC-derived BMC cultures. In addition, there were significant differences in 27% (7 of 26) of the cytokines quantified in HS-derived BMC cultures compared to SC-derived BMC cultures with implications for MSC plasticity and self-renewal.</abstract><cop>New York</cop><pub>Hindawi</pub><pmid>35910535</pmid><doi>10.1155/2022/8259888</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7091-296X</orcidid><orcidid>https://orcid.org/0000-0002-7516-4849</orcidid><orcidid>https://orcid.org/0000-0002-9872-8758</orcidid><orcidid>https://orcid.org/0000-0003-3139-4164</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1687-966X
ispartof Stem cells international, 2022-07, Vol.2022, p.1-12
issn 1687-966X
1687-9678
1687-9678
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6b25d11a690242ff8b82a430e592b8e6
source PubMed (Medline); Wiley-Blackwell Open Access Collection; Publicly Available Content Database
subjects Anticoagulants
Anticoagulants (Medicine)
Biological activity
Bone marrow
Cell culture
Cell self-renewal
Centrifugation
Chemical compounds
Cytokines
Cytology
Fibroblasts
Health aspects
Heparin
Influence
Injury prevention
Mesenchymal stem cells
Morphology
Orthopedics
Pharmacology
Sodium
Sodium citrate
Stem cells
title The Choice of Anticoagulant Influences the Characteristics of Bone Marrow Aspirate Concentrate and Mesenchymal Stem Cell Bioactivity In Vitro
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A37%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Choice%20of%20Anticoagulant%20Influences%20the%20Characteristics%20of%20Bone%20Marrow%20Aspirate%20Concentrate%20and%20Mesenchymal%20Stem%20Cell%20Bioactivity%20In%20Vitro&rft.jtitle=Stem%20cells%20international&rft.au=Dregalla,%20Ryan%20C.&rft.date=2022-07-22&rft.volume=2022&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1687-966X&rft.eissn=1687-9678&rft_id=info:doi/10.1155/2022/8259888&rft_dat=%3Cgale_doaj_%3EA712138548%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c519t-320120d781ede5e6f6e1c77760d7e12905a22d6dcdd0891d7573af59789a7fd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2696738673&rft_id=info:pmid/35910535&rft_galeid=A712138548&rfr_iscdi=true